Nemaura Medical Inc. Stock News

Nemaura Medical Inc. (NASDAQ: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugar

Stocks Analysis by Zacks Investment Research covering: FTSE 100, S&P 500, CAC 40, DAX. Read Zacks Investment Research's latest article on Investing.com

Following the market opening Monday, the Dow traded down 8.73% to 21,162.41 while the NASDAQ fell 8.26% to 7,224.07. The S&P also fell, dropping 8.10% to 2,491.38. South Korea...

Nemaura Medical, Inc. (NASDAQ: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing suga

Nemaura Medical, Inc. (NASDAQ: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing suga

Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares jumped 77.4% to close at $5.80 on Tuesday. Cocrystal Pharma Inc (NASDAQ: COCP) shares surged 64.7% to close at $2.19 on...

The Company announced a partnership with the award-winning UK-based company, Changing Health, to bring digital behavior programs to improve the management, reversal and prevention of Type 2 diabetes i

Beragam berita dan peristiwa di Kota Metropolitan Jakarta dan sekitarnya terjadi selama sepekan terakhir telah diwartakan Kantor Berita ANTARA dan masih layak ...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 27) 10X Genomics Inc (NASDAQ: TXG ) Achillion Pharmace

Replika naga emas sepanjang 45 meter siap memeriahkan puncak perayaan Imlek atau yang dikenal dengan Cap Go Meh di Kota Pontianak, Kalbar, tahun ...

Kepolisian Daerah Kalimantan Barat akan mengerahkan sebanyak 677 personel polisi untuk mengamankan Perayaan Imlek dan Cap Go Meh (CGM) tahun 2020 di provinsi ...

The money will help the company launch its first insulin-management product by the end of this year, which is likely to face stiff competition from larger rivals.

Loughborough, England, Dec. 20, 2019 (GLOBE NEWSWIRE) --  Nemaura Medical, Inc. (NMRD), a medical technology company commercializing sugarBEAT®, a non-invasive and flexible continuous glucose moni

Loughborough, England, Dec. 17, 2019 --   Nemaura Medical, Inc. (NASDAQ:NMRD) (“Nemaura”), a medical technology company commercializing sugarBEAT®, a non-invasive and flexible.

The U.S. Food and Drug Administration on Friday granted approval for Tandem Diabetes Care's software program that uses readings from a continuous glucose monitor to predict and deliver corrective dose